Blood Tests for an 80-Year-Old Man with Parkinson's Disease on Levodopa
For an 80-year-old man with Parkinson's disease taking levodopa, you should order: vitamin D, vitamin B12, folate, and homocysteine levels as essential monitoring tests. 1
Essential Vitamin Monitoring
Vitamin D
- Must be checked and supplemented in all PD patients on levodopa 1
- Low vitamin D levels are consistently found in PD patients compared to healthy controls
- Supplementation may slow disease progression and reduce fracture risk, which is critical in an 80-year-old
- PD patients have lower bone mineral density than age-matched controls, compounding fall risk 1
Vitamin B12 and Folate
- Both should be measured together with homocysteine 1
- Levodopa treatment causes elevation of homocysteine through methylation by catechol-O-methyltransferase (COMT) 1
- Levodopa-treated patients have lower circulating levels of both B12 and folate 1
- The regulation of homocysteine is closely linked to B12 and folate status 1
Homocysteine
- Essential to measure in all levodopa-treated patients 1
- Elevated homocysteine increases with higher levodopa doses, older age, and longer disease duration 1
- Hyperhomocysteinemia is linked to cardiovascular disease, dementia, depression, and neuropathy 1
- Supplementation with B12 and folate effectively reduces homocysteine levels and should be considered to prevent neuropathy and other complications 1
Metabolic Monitoring Considerations
Glucose
- Levodopa can induce glucose intolerance and raise fasting glycemia 1
- Long-term levodopa treatment causes hypersecretion of insulin and growth hormone 1
- Consider checking fasting glucose, particularly in an 80-year-old with likely comorbidities
Standard Laboratory Tests from FDA Label
The FDA label for levodopa 2 notes that routine monitoring should include:
- Complete blood count (CBC) - to monitor for rare but serious hematologic effects including agranulocytosis, hemolytic and nonhemolytic anemia, thrombocytopenia, and leukopenia
- Liver function tests - abnormalities in alkaline phosphatase, AST, ALT, LDH, and bilirubin have been reported
- BUN and creatinine - for renal function monitoring
- Coombs test - if hemolytic anemia is suspected
Clinical Context and Pitfalls
Common pitfall: Failing to recognize that levodopa creates higher vitamin requirements. Many patients take over-the-counter supplements which may mask deficiencies 1, but formal testing ensures adequate levels given the increased metabolic demands.
Age-specific consideration: At 80 years old, this patient has 55% higher systemic levodopa exposure (AUC) compared to younger patients 2, making monitoring for dose-related metabolic effects even more critical.
COMT inhibitor note: If the patient is taking a COMT inhibitor (like entacapone) with levodopa, this may limit homocysteine elevation but doesn't eliminate the need for B12/folate monitoring 1.
The 2018 ESPEN guideline 1 specifically states that vitamin supplementation "should be always considered" to prevent neuropathy and complications, making these tests actionable rather than merely informational.